407 related articles for article (PubMed ID: 37663132)
1. Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives.
Yue NN; Xu HM; Xu J; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Yao J; Liang YJ; Li DF; Wang LS
Mol Ther Oncolytics; 2023 Sep; 30():193-215. PubMed ID: 37663132
[TBL] [Abstract][Full Text] [Related]
2. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders.
Mittal R; Patel AP; Jhaveri VM; Kay SS; Debs LH; Parrish JM; Pan DR; Nguyen D; Mittal J; Jayant RD
Expert Opin Drug Deliv; 2018 Mar; 15(3):301-318. PubMed ID: 29272976
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disorders: gene therapy solutions.
Wirtz S; Neurath MF
Curr Opin Mol Ther; 2003 Oct; 5(5):495-502. PubMed ID: 14601518
[TBL] [Abstract][Full Text] [Related]
5. Insect pathogens as biological control agents: Back to the future.
Lacey LA; Grzywacz D; Shapiro-Ilan DI; Frutos R; Brownbridge M; Goettel MS
J Invertebr Pathol; 2015 Nov; 132():1-41. PubMed ID: 26225455
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. The future of nanomedicine in optimising the treatment of inflammatory bowel disease.
Mohan LJ; Daly JS; Ryan BM; Ramtoola Z
Scand J Gastroenterol; 2019 Jan; 54(1):18-26. PubMed ID: 30678499
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives.
Dos Santos AM; Carvalho SG; Meneguin AB; Sábio RM; Gremião MPD; Chorilli M
J Control Release; 2021 Jun; 334():353-366. PubMed ID: 33901582
[TBL] [Abstract][Full Text] [Related]
9. Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers.
Karim F; Amin A; Liu M; Vishnuvardhan N; Amin S; Shabbir R; Swed B; Khan U
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627127
[TBL] [Abstract][Full Text] [Related]
10. Organizing and Developing a GI Motility Lab in Community Practice: Challenges and Rewards.
Baker JR; Curtin BF; Moshiree B; Rao SSC
Curr Gastroenterol Rep; 2022 Jun; 24(6):73-87. PubMed ID: 35674875
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy: basic concepts and applications in gastrointestinal diseases.
Blum HE; Wieland S; von Weizsäcker F
Digestion; 1997; 58(2):87-97. PubMed ID: 9144296
[TBL] [Abstract][Full Text] [Related]
12. Novel Therapeutic Approaches for the Treatment of Retinal Degenerative Diseases: Focus on CRISPR/Cas-Based Gene Editing.
Gallego C; Gonçalves MAFV; Wijnholds J
Front Neurosci; 2020; 14():838. PubMed ID: 32973430
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy and gene correction: targets, progress, and challenges for treating human diseases.
Cring MR; Sheffield VC
Gene Ther; 2022 Feb; 29(1-2):3-12. PubMed ID: 33037407
[TBL] [Abstract][Full Text] [Related]
14. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease.
Liu W; Dong Z; Liu K; Lu Y; Wu W; Qi J; Chen Z
Int J Pharm; 2021 May; 600():120461. PubMed ID: 33711470
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Nanosystems: Advanced Delivery Tools for Treating Chronic Wounds.
Chu X; Xiong Y; Knoedler S; Lu L; Panayi AC; Alfertshofer M; Jiang D; Rinkevich Y; Lin Z; Zhao Z; Dai G; Mi B; Liu G
Research (Wash D C); 2023; 6():0198. PubMed ID: 37456931
[TBL] [Abstract][Full Text] [Related]
16. Bacterial Membrane Vesicles as Smart Drug Delivery and Carrier Systems: A New Nanosystems Tool for Current Anticancer and Antimicrobial Therapy.
Aytar Çelik P; Erdogan-Gover K; Barut D; Enuh BM; Amasya G; Sengel-Türk CT; Derkus B; Çabuk A
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111538
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy Strategies Targeting Aging-Related Diseases.
Yu J; Li T; Zhu J
Aging Dis; 2023 Apr; 14(2):398-417. PubMed ID: 37008065
[TBL] [Abstract][Full Text] [Related]
18. Vectors and strategies for nonviral cancer gene therapy.
Pahle J; Walther W
Expert Opin Biol Ther; 2016; 16(4):443-61. PubMed ID: 26761200
[TBL] [Abstract][Full Text] [Related]
19. Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease.
Shinn J; Lee J; Lee SA; Lee SJ; Choi AH; Kim JS; Kim SJ; Kim HJ; Lee C; Kim Y; Kim J; Choi J; Jung B; Kim T; Nam H; Kim H; Lee Y
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145716
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophages and their potential for treatment of gastrointestinal diseases.
Duan Y; Young R; Schnabl B
Nat Rev Gastroenterol Hepatol; 2022 Feb; 19(2):135-144. PubMed ID: 34782783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
